Drug Discovery

#Drug discovery

ABPI responds to UK Brexit medicine stockpiling guidance

The UK’s Department of Health and Social Care has published a letter setting out its government’s plan and requests of industry and the wider supply chain ahead of the end of the Brexit transition period. This aims to help ensure the continuity of supply of medical goods into… Read More

#Covid-19 #News

#AI / data analytics / healthtech / informatics #Analysis #Assay development optimisation & technology #Automation / robotics #Cell therapy #Drug development #Drug discovery #Gene therapy #Immunology #Lead discovery #Oncology #Pathology #Precision medicine #RNA #Screening #Stem cells #Therapeutics

Researchers discover cell communication mechanism that drives cancer adaptation

Collaborative Cancer Research UK-funded studies from University of Oxford researchers have uncovered a new mechanism by which cancer cells adapt to the stresses they encounter as they grow and respond to therapies. This mechanism involves cells releasing small vesicles, known as exosomes. These contain complex mixtures of proteins,… Read More

#Cancer Research #Covid-19 #News

#Business #Drug development #Drug discovery #High Content Screening #Immunology #Immunology / Virology & Vaccines #Lead discovery #Oncology #Preclinical #Regulatory #Stem cells

Cancer Research UK collaborate to develop head and neck cancer vaccine

This a new clinical development partnership to progress a therapeutic DNA vaccine, TGL-100, into an early phase clinical trial targeting head and neck squamous cell carcinoma (HNSCC) HNSCC is the UK’s eighth most common cancer, but treatment options are limited and around 4,000 of those affected in the… Read More

#Cancer Research #News

#AI / data analytics / healthtech / informatics #Business #Computational chemistry #Drug development #Drug discovery #Drug targets #Gene therapy #Molecular medicine #Orphan drugs #Precision medicine

Centogene and Molecular Health collaborate to develop orphan drugs

Image: Fabio Centogene and Molecular Health, are to collaborate on the Real-life data and Innovative Bioinformatic Algorithms (RIBA) project, starting with epilepsy as the first indication. RIBA aims to foster a unique novel precision medicine environment to accelerate, de-risk, and improve the development of new orphan drugs based… Read More

#News

#Academic #Business #Cell therapy #Cellular assays #Clinical specialities #Drug development #Drug discovery #Enabling technologies #Genomics #High Content Screening #High throughput screening #Imaging #Lead discovery #Microfluidics #Screening #Stem cells #Target validation #Therapeutics #Translational #Translational chemistry

Drug target for aggressive breast cancer found

A team of British and American scientists has discovered a way to slow the growth of breast cancer stem cells in the lab. The study led by Dr Bruno Simões and Professor Rob Clarke from The University of Manchester could eventually lead to combination drug therapies on previously… Read More

#Cancer Research #News

#AI / data analytics / healthtech / informatics #Business #Drug discovery #Target validation

Thermo Fisher expands options for SampleManager LIMS

Thermo Fisher Scientific has expanded available options for SampleManager LIMS software, offering laboratories end-to-end support of the software deployment in the Amazon Web Services (AWS) Cloud. Under a contract agreement, Thermo Fisher will manage the process from installation and maintenance to backup and recovery. Labs will benefit from… Read More

#News

#Biologics / Biotechnology #Clinical trials #Drug development #Drug discovery #Gene therapy #Immunology / Virology & Vaccines #Lead discovery #Regulatory #RNA

Phase III clinical trial of investigational vaccine for COVID-19 begins in US

Multi-site trial to test candidate developed by Moderna and NIH. A Phase III clinical trial designed to evaluate if an investigational vaccine can prevent symptomatic coronavirus disease 2019 (COVID-19) in adults has begun. The vaccine, known as mRNA-1273, was co-developed by the Cambridge, Massachusetts-based biotechnology company Moderna and… Read More

#Covid-19 #News

#Academic #Business #Cellular & Molecular biology #Cellular assays #Clinical trials #Drug development #Drug discovery #Enabling technologies #Genomics #High Content Screening #High throughput screening #Imaging #Immunology / Virology & Vaccines #Microfluidics #Screening #Stem cells #Therapeutics #Translational #Translational chemistry

UK government advises drug companies to stockpile in case of Brexit disruption

Image: Joshua Coleman According to the Department of Health and Social Care (DHSC), pharmaceutical companies should stockpile six weeks’ worth of goods “to help ensure the continuity of supply of medical goods into and out of the UK”. In a letter to the industry Steve Oldfield, Chief Commercial Officer,… Read More

#Covid-19 #News

#Business #Clinical trials #Drug development #Drug discovery #Imaging #Immunology / Virology & Vaccines #Lead discovery #Regulatory #RNA

GSK and Sanofi to supply US government with 100 million doses of COVID-19 vaccine

Sanofi and GSK have announced a collaborative effort with the US government to accelerate the development and manufacturing of a COVID-19 recombinant protein-based vaccine. The vaccine candidate, developed by Sanofi in partnership with GSK, is based on the recombinant protein-based technology used by Sanofi to produce an influenza… Read More

#Covid-19 #News

#Business #Drug development #Drug discovery #Genetics / genomes #Immunology #Oncology #Therapeutics

Horizon Discovery licenses platform to TrueBinding for biotherapeutics development

TrueBinding, a biopharmaceutical company, has signed a set of commercial licenses for Horizon Discovery’s CHOSOURCE platform. TrueBinding will use the cGMP-compliant platform for the development and commercialisation of multiple biotherapeutic products for applications in immuno-oncology and other disease areas with great unmet medical need. Horizon’s CHOSOURCE platform includes a gene-edited… Read More

#News

#Drug development #Drug discovery #Imaging #Lead discovery #QA/QC #RNA #Screening

NanoImaging Services opens West Coast facility to help grow of its CryoEM network

NanoImaging Services, has opened a new facility close to its San Diego headquarters. The new data collection centre will be the largest private facility for cryoEM data collection globally, says the company, and will serve both national and international clients. Designed to be a data collection farm, this… Read More

#News

#Automation / robotics #Business #Drug discovery

SLAS2021 goes digital

Image: Rodion Kutsaev SLAS2021 will now be a fully digital experience as well as a celebration of 10 years of laboratory automation, scientific education and innovation. The event will be free for SLAS Premier Members and students with registration opening in October. Advantages of SLAS2021 Digital: More members of… Read More

#News

#Clinical trials #Drug development #Therapeutics

Parkinson’s UK backs NRG Therapeutics’ breakthrough drug development

Parkinson’s UK has invested an additional £1 million in NRG Therapeutics mitochondrial drug development programme. This funding boost, on top of an initial £1 million investment, will support the development of a breakthrough drug with the potential to slow or halt the progression of Parkinson’s – something no… Read More

#Covid-19 #News

#Analysis #Drug development #Drug discovery #Drug targets #Lead discovery #Regulatory #RNA

Analysis could find drug targets for attention deficits and sensory hypersensitivity

Image: Jesse Orrico Many people with autism experience sensory hypersensitivity, attention deficits and sleep disruption. One brain region implicated is the thalamic reticular nucleus (TRN), which is believed to act as a gatekeeper for sensory information flowing to the cortex, by Anne Trafton, MIT News Office A team… Read More

#News

#Cell therapy #Drug development #Drug discovery #Gene therapy #Genetics / genomes #Immunology #Regulatory #RNA #Stem cells

How the regulator is regulated: insight on immune-related protein holds therapeutic value

Image: National Cancer Institute Scientists unravel how the immune checkpoint protein PD-L2 is regulated, which has potential implications in immune therapy Various proteins expressed in cells of the immune system have shown to play an important role in various disorders, including cancer, allergy, and autoimmune disease. In a… Read More

#News

#Analysis #Drug development #Drug discovery #Genetics / genomics #Genomics #Oncology #RNA

Genetic study says iron levels could be key to ageing slowly

30 July 2020 Image: Sven Mieke Genes linked to ageing that could help explain why some people age at different rates to others have been identified by scientists. The international study using genetic data from more than a million people suggests that maintaining healthy levels of iron in… Read More

#News